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Gene conversion (GCV), a mechanism mediated by activation-induced cytidine deaminase
(AID)iswellestablishedasamechanismofimmunoglobulindiversiﬁcationinafewspecies.
However, deﬁnitiveevidenceofGCV-likeeventsinhumanimmunoglobulingenesisscarce.
The lack of evidence of GCV in human rearranged immunoglobulin gene sequences is puz-
zling given the presence of highly similar germline donors and the presence of all the
enzymatic machinery required for GCV. In this study, we undertook a computational analy-
sis of rearranged IGHV3-23∗01 gene sequences from common variable immunodeﬁciency
(CVID) patients, AID-deﬁcient patients, and healthy individuals to survey “GCV-like” activ-
ities. We analyzed rearranged IGHV3-23∗01 gene sequences obtained from total PBMC
RNA and single-cell polymerase chain reaction of individual B cell lysates. Our search iden-
tiﬁed strong evidence of GCV-like activity. We observed that GCV-like tracts are ﬂanked
by AID hotspot motifs. Structural modeling of IGHV3-23∗01 gene sequence revealed that
hypermutable bases ﬂanking GCV-like tracts are in the single stranded DNA (ssDNA) of
stable stem-loop structures (SLSs). ssDNA is inherently fragile and also an optimal target
for AID.We speculate that GCV could have been initiated by the targeting of hypermutable
bases in ssDNA state in stable SLSs, plausibly by AID. We have observed that the fre-
quency of GCV-like events is signiﬁcantly higher in rearranged IGHV3-23-∗01 sequences
from healthy individuals compared to that of CVID patients. We did not observe GCV-like
events in rearranged IGHV3-23-∗01 sequences from AID-deﬁcient patients. GCV, unlike
somatic hypermutation (SHM), can result in multiple base substitutions that can alter many
amino acids.The extensive changes in antibody afﬁnity by GCV-like events would be instru-
mental in protecting humans against pathogens that diversify their genome by antigenic
shift.
Keywords: human immunoglobulin gene, gene conversion, homologous recombination, activation-induced cyti-
dine deaminase, DNA secondary structure, afﬁnity maturation
INTRODUCTION
Diverse mechanisms form the primary immune repertoire. In
manyspecies,thepresenceof multiplefunctionalvariabledomain
encoding gene segments allows a large and signiﬁcant diversity
in the primary antibody repertoire by the mechanism of V(D)J
recombination alone (Tonegawa, 1983; Alt et al., 1987; Pascual
and Capra, 1991). In contrast, chicken has a sole functional VH
and a sole functional VL gene segment, and hence, the primary
diversity generated through V(D)J recombination is minimal. In
chicken, the predominant and powerful mechanism of antibody
diversiﬁcation is “Gene Conversion” (GCV; Reynaud et al., 1987,
1989;Sayegh et al.,1999;Arakawa and Buerstedde,2004;Ratcliffe,
2006). GCV is a “copy and paste” type of non-reciprocal trans-
fer of genetic information between homologous DNA sequences
(Wysocki and Gefter, 1989). Recombination events in mammals
facilitating non-reciprocal transfer of sequences are called“GCV-
like events” because the unidirectional transfer of sequence is
inferred from the sequence homology between the donor and
recipientsequences(indirectly)ratherthaninorganismslikefungi
wherenon-reciprocityof eventscanbeseendirectly,insinglecells
(Radding, 1978; Hastings, 1988). In chicken, over 25 pseudo vari-
ablegenesegmentslieupstreamofthesolefunctionalvariablegene
segment.Theseupstreampseudogenesare(orcanbe)usedastem-
platestoreplacehomologoussequencesoffunctionallyrearranged
VJ and VDJ gene segments (McCormack et al., 1991; Reynaud
et al.,1994). Multiple rounds of GCV events,thereby,diversify the
primary antibody repertoire. In rabbit, although there are mul-
tiple functional and non-functional VH gene segments, 80–90%
of rearrangements utilize only one VH gene segment, VH1, with
the other VH gene segments being utilized as templates for GCV
(Becker and Knight, 1990; Weinstein et al., 1994; Winstead et al.,
1999; Sehgal et al., 2000). Although the combinatorial diversity at
the light chain loci in rabbit is much higher than that at the heavy
chain loci, GCV is visibly used to diversify the light chain gene
segments (Sehgal et al., 2000). There is also evidence of GCV for
the diversiﬁcation of Vλ repertoire of cattle (Parng et al., 1996;
Lucier et al., 1998). Some good evidence of GCV has been found
in mice (Dildrop et al., 1982; Krawinkel et al., 1983; David et al.,
1992; Selsing et al., 1996; D’Avirro et al., 2002, 2005; Tsai et al.,
2002). GCV in human rearranged immunoglobulin genes have
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not been identiﬁed except for one recent study (Darlow and Stott,
2006).
ItappearsthatspeciesthatemployGCVaspredominantdiver-
siﬁcation mechanism have limited functional gene segments or
restricted usage of them. Additionally, in these species it appears
that most V(D)J recombination directed gene rearrangements
occur only early in their life cycle and cease to occur in adult
life (McCormack and Thompson, 1990; Reynaud et al., 1991;
Griebel and Ferrari, 1994; Parng et al., 1996; Meyer et al., 1997).
Immunoglobulin diversiﬁcation in chickens, rabbits, and cattle
occurs by additional mechanisms upon antigenic challenge but
GCV is a key mechanism. Infrequent GCV events in humans
could be due to the species’ high dependence on V(D)J recom-
bination and hence there is less need for GCV to generate the
vast, diverse primary antibody repertoire. Moreover, in humans,
gene rearrangements occur throughout life facilitating extensive
and continuing diversity. In species where vast diversity can be
generated by combinatorial joining of multiple functional gene
segments or in species such as sheep where diversity seems to
be generated in most part by somatic hypermutation (SHM;
Reynaud et al., 1991; Reynaud et al., 1995), it is not necessary
to conclude that GCV is an unlikely mechanism of diversiﬁca-
tion. Immunoglobulin VH genes belong to multigene families
(Hood et al., 1975). Members of a multigene family share exten-
sive sequence homology and thus can participate in interactions
such as recombination and GCV that can multiply their diversity.
Species such as chickens and rabbits provide a unique oppor-
tunity to analyze GCV since the limited usage of functional V
gene segments makes the identiﬁcation of germline counterparts
quite straight forward. Humans can utilize several hundred func-
tionalVgenesegmentsmakingitdifﬁculttoassignexactgermline
counterparts for their diversiﬁed genes. The dominant diversify-
ing mechanisms could well mask GCV tracts. Multiple rounds of
GCVeventsmayappeartobeSHMssincenotonlyisitdifﬁcultto
identify the germline segments that participated in GCV but also
SHMs may be superimposed on a GCV event further masking the
process.
Activation-induced cytidine deaminase (AID) is an enzyme
required for immunoglobulin diversity (Muramatsu et al., 2000;
Revy et al., 2000). The absence of AID in B cells results in the
absence of three immunoglobulin diversiﬁcation mechanisms:
SHM, class-switch recombination (CSR), and GCV (Muramatsu
et al., 2000; Revy et al., 2000; Arakawa et al., 2002; Harris et al.,
2002). An AID-induced lesion is the initiating lesion in all three
processes.ThedownstreamconsequenceswheretheAID-induced
lesion is resolved, however, are different. AID converts cytidine
to uracils, a process that results in high levels of AID-dependent
resected-end DSBs’s in V-genes (Bross et al., 2002; Papavasiliou
and Schatz, 2002; Wu et al., 2003; Zan et al., 2003). Resected
ends (3 ) are involved in homologous recombination (HR) repair.
HR is considered to the mechanism of GCV in immunoglobu-
lin gene segments (Bezzubova and Buerstedde,1994; Papavasiliou
and Schatz, 2000). Further DSB’s in V-genes have been shown to
preferentially target RGYW motifs, with embedded AID hotspot
motifs (WRC/GYW; Bross et al., 2000; Papavasiliou and Schatz,
2000). Data also suggest that unidirectional GCV requires chro-
matin to be in an open state (Roth and Roth,2000;Schlissel,2000;
Seo et al., 2005; Kurosawa et al., 2010), which, during transcrip-
tion,generatesthesinglestrandedregionsrequiredforAIDaction
(Dickerson et al.,2000; Bransteitter et al.,2003; Pham et al.,2003;
Ramiroetal.,2003;OdegardandSchatz,2006;Larijanietal.,2007).
It is puzzling to envision the absence or lack of GCV in human
rearranged immunoglobulin gene segments when there is pres-
ence of required machinery for GCV, i.e., from AID to enzymes
required for HR and their resolution by mismatch repair (MMR)
and error-prone polymerases (Seki et al., 2005; Liu and Schatz,
2009).
In this study, we made use of the development of genomic
databases and bioinformatics software to analyze the rearranged
IGHV3-23∗01 gene from common variable immunodeﬁciency
(CVID)patients,AID-deﬁcientpatients,andhealthyindividualsto
explore“GCV-like”activities. We chose IGHV3-23∗01 rearrange-
ments because they comprise approximately 25% of all IGHV3
family rearrangements in normal adult peripheral B cells and the
germline number of the IGHV3 family gene segments allowed
the analyses to be signiﬁcant.We analyzed mutated IGHV3-23∗01
sequences obtained by two methods (1) RT-PCR of total PBMC
RNA(2)Single-cellpolymerasechainreaction(PCR)ofindividual
B cell lysates.
During our search for germline donors for mutations in
rearranged IGHV3-23∗01,we found examples of GCV-like events
that could have contributed to the diversity of IGHV3-23∗01 post
VDJ rearrangement. In our previous studies (Duvvuri et al.,2011,
2012)weprovidedevidencefordefectiveDNArepairmechanisms
in a subgroup of CVID patients. These patients had functional
AID as evidenced by the presence of SHM and by a switch in
immunoglobulinclassof theirimmunoglobulingenes.Inthecur-
rent analyses rearranged IGHV3-23∗01 from these CVID patients
showedasigniﬁcantlyreducedfrequencyof GCV-likeeventscom-
pared to that of healthy individuals. We did not ﬁnd any evidence
of GCV-like events from our analysis of sequences from AID-
deﬁcient patients in the data bases. Using modeling software and
analysis,we demonstrate the presence of sequences and structures
associatedwithsite-speciﬁcrecombinationintheregionsﬂanking
GCV-like events. Finally we discuss the contribution of GCV in
afﬁnity maturation and receptor editing.
MATERIALS AND METHODS
DNA SEQUENCE DATA COLLECTION
For the CVID patients, IGHV3-23 (also called VH26) cDNAs
were obtained by Dr. C. A. Reynaud at the Necker Institute,
Paris as described (Levy et al., 1998). Brieﬂy, the sequences
were ampliﬁed by RT-PCR using total PBMC RNA as tem-
plate. A “downstream” Cγ primer was used to ensure that the
sequences arose from class-switched B cells. The CγA primer
(GTCCTTGACCAGGCAGCCCAG) was used for single strand
cDNA synthesis using an RT-PCR kit (Stratagene). PCR was then
performed with 0.5 unit of Pfu polymerase on cDNA. The fol-
lowing primers were used for ampliﬁcation: V3–23 leader exon
(GGCTGAGCTGGCTTTTTCTTGTGG-3 ) and CγB (AAGACC-
GATGGGCCCTTGGTGG). The PCR conditions were 35 cycles
(940˚C, 45s; 650˚C, 1.5min; 720˚C, 2min).
Healthy control samples (C1–C5 series) were obtained as
described (Pan-Hammarström et al., 2006). Brieﬂy, total RNA
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was extracted from PBMC using RNeasy RNA puriﬁcation kits
(QIAGEN) and ﬁrst-strand cDNA synthesis was performed with
aC γA primer (GTCCTTGACCAGGCAGCCCAG) using a cDNA
synthesis kit (GE Healthcare). The primers used for ampliﬁca-
tionofVH3-CγandVH3–23-CγtranscriptswereVH3-consensus
(aatctagaGGTGCAGCTGGTGGAGTC), VH3–23 (tctagaGGCT-
GAGCTGGCTTTTTCTTGTGG), and CγB (cagtcgacAAGACC-
GATGGGCCCTTGGTGG). The oligonucleotides contained a
restriction site, (underlined, a XbaI site in the VH3-consensus or
VH3–23 primer and a SalI site in the CγB primer) for directional
cloning of the PCR products.
Detailed analysis of IGHV3-23∗01 sequence data from CVID
patients and healthy individuals is in Duvvuri et al. (2011,2012).
DATABASE OF IGHV3-23∗01 MUTATED SEQUENCES FROM HUMAN
PERIPHERAL B CELLS USING SINGLE-CELL POLYMERASE CHAIN
REACTION
In total we have screened 636 VH productive rearrangements
from healthy controls for IGHV3-23∗01 rearranged sequences.
The ﬁnal analysis included 81, IGHV3-23∗01 sequences from
healthy controls from different subsets of B cells and details are
as followed: 15, IGHV3-23∗01 sequences from CD19+IgM+ B
cells, 52, IGHV3-23∗01 sequences from CD19+IgM+CD5+ and
CD19+IgM+CD5−Bcells(Brezinscheketal.,1995,1997;Dörner
et al., 1998); 11, IGHV3-23∗01 sequences from IgD+CD27+ B
cells; and 3, IGHV3-23∗01 sequences from IgD−CD27+ Bc e l l s
(Longo et al.,2008). FromAID-deﬁcient patients,in total we have
screened 1150 VH productive rearrangements for IGHV3-23∗01
rearranged sequences. The ﬁnal analysis included 117, IGHV3-
23∗01sequencesfromCD19+IgM+CD5+andD19+IgM+CD5-
B cells (Longo et al., 2008). All the sequences have been obtained
from NCBI.
COMPUTATIONAL APPROACHES USED FOR THE IDENTIFICATION OF
GCV-LIKE TRACTS IN IGHV3-23∗01 SEQUENCES
Gene conversion-like events in IGHV3-23∗01 gene were sought
employing two different computational approaches. The ﬁrst
approach employed the tool GENECONV1 (Sawyer, 1989).
GENECONVisthehighlyrankedrecombinationanalysissoftware
and is included in the RDP2 analysis suite. Since we are analyzing
hypermutated IGHV3-23∗01 gene sequences,it is possible to have
GCV tracts masked by point mutations (as a result of SHM) and
thus GENECONV would underestimate the occurrence of GCV
events.
All possible germline sequences of rearranged (hypermutated)
IGHV3-23∗01 sequences were identiﬁed in JoinSolver alignment
program available at http://joinsolver.niaid.nih.gov/.
As a second approach, we visually checked the alignments
between rearranged and germline sequences in BioEdit, a bio-
logical sequence alignment editor (using default parameters), to
identify possible GCV tracts.
GENECONV DETECTION METHODOLOGY
GENCONV is a program speciﬁcally designed to identify GCV
events. GENECONV searches for potential past GCV events by
1http://www.math.wustl.edu/ sawyer/geneconv
searching for highly similar sequences in an entire alignment. It
determinesthestatisticalsigniﬁcanceofobservedfragmentlengths
by computing global and pairwise P-values. Sequence pairs with
low P-value, (by default P-value<0.05) are considered statis-
tically signiﬁcant. Pairwise P-values are assigned based on the
comparisonof eachfragmentwiththemaximumfragmentlength
that might have been expected for that sequence pair by chance.
Pairwise P-values are approximate P-values based on Karlin and
Altschul P-value (Karlin and Altschul,1990),which is the basis of
the highly used BLAST method for ﬁnding sequence matches in
DNAorproteindatabases.GlobalP-values,ontheotherhand,are
moreconservativebecausetheyarebasedonacomparisonof each
fragmentforallpossiblepairsreportedfromanalignment.Global
P-values are assigned based on permutations and GENECONV
by default considers 10,000 permutations for each tested sequence
alignment. GENECONV default settings for the analysis of align-
mentsof threeormoresequenceswereusedfortheentireanalysis.
Additionally,we also used – Dumpjseq option,which predicts the
bases immediately adjacent to the endpoints of signiﬁcant GCV
fragments displayed as: before <Frag.....ment> After. Input for
GENECONV is an alignment of IGHV3-23∗01 DNA sequences
with germline VH sequences. Possible donor germline sequences
were identiﬁed by screening each of the rearranged (hypermu-
tated) IGHV3-23∗01 sequences (n =161 from CVID patients by
RT-PCRof totalPBMCRNA;n =117fromAID-deﬁcientpatients
by single-cell PCR of individual B cell lysates; n =40 from healthy
controls by RT-PCR of total PBMC RNA and n =81 from healthy
controls by single-cell PCR of individual B cell lysates).
DNA SECONDARY STRUCTURAL ANALYSIS
Mfg is a tool to analyze DNA secondary structures. It was
used to analyze the IGHV3-3∗01 germline gene during sim-
ulated transcription. In a given window size “mfg” folds all
nucleotides successively, beginning with each base and predicts
the most stable (−ΔG) stem-loop structures (SLSs), in which
that base is unpaired and therefore assumed to have longest
period of exposure time to AID. −ΔG values document the
negative free energy. The more negative the −ΔG value, the
more likely is the stable is the SLS. Mfg calculates the frequency
with which a speciﬁc base is unpaired in the most stable SLS
Table 1 | Identities between germline IGHV3-23*01 gene sequence and
potential germlineVH donors for GCV-like eventsa.
Identiﬁed donors of GCV-
like events sequences
Identity with germline IGHV3-
23*01 gene sequence (%)
IGHV3-09*01 89
IGHV3-11*01 90
IGHV3-19*01 88
IGHV3-21*01 91
IGHV3-43*02 89
IGHV3-48*03 92
IGHV3-60*01 87
IGHV3-64*04 92
aAlignments are shown in Figures 1–4.
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FIGURE 1 | Gene conversion-like events between rearranged
IGHV3-23*01 gene sequences and germlineVH sequences identiﬁed
by GENECONV. Alignments of rearranged IGHV3-23*01 gene sequences
and germline donor VH sequences demonstrating the minimum and
maximum homology at GCV-like events.Topmost sequence is the
germline of rearranged IGHV3-23*01 gene sequences from a healthy
individual (C2–8) and a CVID patient (P1–5). Potential donor germline
IGHV3 family gene segments are shown below the rearranged
IGHV3-23*01 sequences. GCV-like tract is underlined. Flanking SHM/AID
hotspot motifs are underlined and italicized.
during simulated transcription giving the result as a “percent
unpaired.” More detailed information on the software is avail-
able in Wright et al. (2003, 2004, 2008a,b, 2011) and on the web
sitewww.dbs.umt.edu/research_labs/wrightlab/upload/mfg.html.
A base is called unpaired or paired when present in the loop or in
the stem respectively.
RESULTS
IDENTIFICATION OF HOMOLOGY BETWEEN IGHV3-23∗01 AND
POTENTIAL GERMLINE GCV DONOR’S VH REGIONS
For evidence of GCV-like diversiﬁcation we ﬁrst searched for
homologieswiththegermlineVHgenesthatcouldserveasdonors.
Templated mutations in GCV require some (∼>80%) degree of
homology between donor and recipient target sequences. Table 1
showstheglobalhomologybetweenIGHV3-23∗01 gene sequence
and all potential GCV-like donors identiﬁed. IGHV3-23∗01 is
the germline sequence of the rearranged IGHV3-23∗01 sequences
being analyzed.
CHARACTERIZATION OF GCV-LIKE EVENTS IN REARRANGED
IGHV3-23∗01 SEQUENCES
To identify GCV-like events in rearranged IGHV3-23∗01 gene
sequences, we searched the germline human IGVH locus data
bases for matches to the mutated IGHV3-23∗01 gene sequences.
The IGHV3-23∗01 gene sequences were collected from data bases
of sequences from healthy individuals, CVID, and AID-deﬁcient
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patients, Figure 1 shows statistically signiﬁcant regions of GCV-
like events identiﬁed by GENECONV in rearranged IGHV3-
23∗01 gene sequences, that had undergone afﬁnity maturation
as evidenced by the presence of SHM (henceforth referred to
as hypermutated IGHV3-23∗01 gene sequences). Figure 1 con-
tains the analysis of IGHV3-23∗01 gene sequences extracted from
a healthy individual and a CVID patient, total PBMC RNA;
Figures 2–4 contains analysis of IGHV3-23∗01 gene sequences
extracted from single-cell PCR of B cells from healthy indi-
viduals (details in Materials and Methods). No evidence of
GCV-like events was identiﬁed in from IGHV3-23∗01 sequences
extracted from single-cell PCR of B cells from AID-deﬁcient
patients. Germline VH donors, tract length, and P-values from
GENECONV are shown in Tables 2 and 3. The observed base
substitutions in GCV-like events show clustered nucleotide differ-
ences, an unvarying characteristic of GCV, and thus striking evi-
dence for GCV. Inspection of the IGVH locus2 revealed that both
upstream and downstream germline VH genes were involved in
2http://www.imgt.org/
the diversity of rearranged IGHV3-23∗01 gene sequences through
GCV-like mechanisms. Germline VH gene donors downstream
of IGHV3-23∗01are:IGHV3-9∗01,IGHV3-11∗01,IGHV3-19∗01,
and IGHV3-21∗01. Germline VH gene donors upstream of
IGHV3-23∗01 are: IGHV3-43∗02, IGHV3-48∗03, IGHV3-60∗01
(a pseudogene),and IGHV3-64∗04. All germline donorVH genes
are functional unless so noted. The implication of these results is
discussed below.
GERMLINE VH DONORS FOR SILENT MUTATIONS
AsshowninFigures1–4,GCV-likeeventswerefoundtobespread
in all regions of the VH sequence (CDR1, FR2, CDR2, and FR3).
All base substitutions are shown in Tables 4 and 5. Replacement
mutations are the result of both mutagenic mechanisms and the
intenseselectionpressurethatreplacementmutationshaveunder-
gone during afﬁnity maturation. In order to distinguish between
changesduetomutationsfromchangesduetoantigenicselection,
we analyzed silent mutations for germline matches. Silent muta-
tions as a result of GCV-like events represented more than 25% of
nucleotide changes (Tables 4 and 5).
FIGURE 2 | Gene conversion-like events between rearranged
IGHV3-23*01 gene sequences and germlineVHsequences superimposed
by somatic hypermutation (SHM). IGHV3-23*01 mutated sequences
obtained by single-cell PCR from CD19+IgM+B cells (Brezinschek et al.,
1995, 1997; Dörner et al., 1998; Longo et al., 2008).Topmost sequence is the
germline of rearranged IGHV3-23*01 gene sequences from healthy
individuals (X87050.1, X87049.1, and X87051.1) Potential donor germline
IGHV3 family gene segments are shown below the rearranged IGHV3-23*01
sequences. GCV-like tract is underlined. Flanking SHM/AID hotspot motifs are
underlined and italicized.
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FIGURE 3 | Gene conversion-like events between rearranged
IGHV3-23*01 gene sequences and germlineVH sequences superimposed
by somatic hypermutation (SHM). IGHV3-23*01 mutated sequences
obtained by single-cell PCR from CD19+IgM+CD5+ B cells (Brezinschek
et al., 1995, 1997; Dörner et al., 1998; Longo et al., 2008).Topmost sequence
is the germline of rearranged IGHV3-23*01 gene sequences from healthy
individuals (Z80511.1, Z80523.1, and Z80644.1). Potential donor germline
IGHV3 family gene segments are shown below the rearranged IGHV3-23*01
sequences. GCV-like tract is underlined. Flanking SHM/AID hotspot motifs are
underlined and italicized.
PRESENCE OF SEQUENCE-SPECIFIC MOTIFS POTENTIALLY INVOLVED
IN SITE-SPECIFIC RECOMBINATION
Several speciﬁc sequences or motifs are recognized by specialized
enzymes that can cause DSBs and thus initiate HR through GCV
or reciprocal exchanges (Flanagan et al., 1984; Kilpatrick et al.,
1984;López-Correaetal.,2001;Leeetal.,2002;Chuzhanovaetal.,
2009). SHM, GCV, and CSR have all been shown to be initiated
by DSBs (Brenner and Milstein, 1966; Wuerffel et al., 1997;
Frontiers in Immunology | B Cell Biology June 2012 | Volume 3 | Article 158 | 6Duvvuri and Wu Diversiﬁcation of human IGHV3-23*01 gene
FIGURE 4 | Gene conversion-like events between rearranged
IGHV3-23*01 gene sequences and germlineVH sequences superimposed
by somatic hypermutation (SHM). IGHV3-23*01 mutated sequences
obtained by single-cell PCR from CD19+IgD+CD27+ B cells (Brezinschek
et al., 1995, 1997; Dörner et al., 1998; Longo et al., 2008).Topmost sequence
is the germline of rearranged IGHV3-23*01 gene sequences from healthy
individuals (EF542581.1 and EF542586.1). Potential donor germline IGHV3
family gene segments are shown below the rearranged IGHV3-23*01
sequences. GCV-like tract is underlined. Flanking SHM/AID hotspot motifs are
underlined and italicized.
Papavasiliou and Schatz, 2000; Chen et al., 2001; Petersen et al.,
2001;Catalanetal.,2003;Rushetal.,2004;TangandMartin,2006).
Like SHM, DSBs also preferentially target SHM hotspot motifs,
RGYW/WRCY, in rearranged immunoglobulin genes (Papavasil-
iou and Schatz, 2000, 2002; Bross et al.,2002; Wu et al.,2003; Zan
et al., 2003). Figures 1–4, show the ﬂanking regions of GCV-like
tracts with SHM/AID hotspot motifs italicized and underlined
in the germline IGHV3-23∗01 sequence. We speculate, based on
strongevidenceintheliteraturethattheseSHMmotifscouldhave
played a role in initiating the DSB’s and/or could be the targets of
AID for resection of 5  ends.
PRESENCE OF STRUCTURES THAT PROMOTE GCV
Regions of the genome that tend to form non-B DNA confor-
mations, such as stable SLSs, are susceptible to DSB’s, which
in turn could initiate GCV through HR (Bacolla and Wells,
2004; Bacolla et al., 2004; Wang and Vasquez, 2006; Chen et al.,
2007; Wells, 2007). The generation of SLS’s in immunoglobu-
lin genes is coupled to transcription. Transcription can alter the
DNA conformation which can fold into secondary structures
exposing DNA largely in single stranded state. Single stranded
DNA (ssDNA) is inherently fragile and can be the target of
enzymes generating DSBs.
With substantial evidence showing that RGYW/WRCY motifs
are preferential targets of DSB’s and resected ends during SHM,
we undertook structural analysis of bases that are present at or
nearest to the break points of GCV-like tracts (5  and 3 ). The
hypermutable bases in the ﬂanking regions of GCV-like tracts for
which structures are drawn are italicized in Figures 1–4. Since
SHM (and AID) targeted bases are predominantly C’s and G’s,we
analyzed the paired or unpaired state of C’s or G’s at or nearest to
GCV-break points. We used the germline non-transcribed strand
(NTS) of IGHV3-23∗01 for the structural analysis through sim-
ulated transcription using the DNA secondary structural analysis
tool, “mfg.” “Mfg” predicts the most stable SLS in which a par-
ticular base is unpaired. The propensity of a base to be in the
single stranded condition is quantiﬁed as the percent unpaired
(%UP) and the stabilities of the SLSs as −ΔGs’ are shown in
Figure5.Figure5representsthemoststableSLSsinwhichhyper-
mutable bases that are present at GCV-break points are exposed
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Table 2 | Characteristics of GCV-like tracts predicted by GENECONV in
rearranged IGHV3-23*01 gene sequences.
Recipient
sequence
namea
Germline
donor
sequence
GCV-like tract
length (in
nucleotides)
Sim
P-valueb
Sim
P-valuec
C2–8 IGHV3-11*01 8 0.0059 0.0019
C2–8 IGHV3-09*01 3 0.0188 0.0088
C2–8 IGHV3-43*02 3 0.0046 0.0022
P1–5 IGHV3-09*01 13 0.0101 0.0384
P1–5 IGHV3-11*01 47 0.0022 0.0014
P1–5 IGHV3-43*02 13 0.0059 0.0128
Alignments are shown in Figure 1.
aSequences starting with C and P are from healthy individuals and CVID patients
respectively. IGHV3-23*01 sequences obtained by RT-PCR of total PBMC RNA
(Levy et al., 1998; Pan-Hammarström et al., 2006).
bSimulated P-values of the global inner fragments obtained from 10,000 permu-
tations.
cPairwise P-values based on a method of Karlin and Altschul (1990).
Table 3 | Characteristics of GCV-like tracts superimposed by SHM
(identiﬁed by visual inspection of alignments).
Recipient
sequence namea
Germline donor
sequence
GCV-like tract length
(in nucleotides)
X807049.1 IGHV3-21*01 62
X807050.1 IGHV3-43*02 14
IGHV3-09*01
X807051.1 IGHV3-19*01 50
Z80511.1 IGHV3-48*03 11
Z80523.1 IGHV3-64*04 47
Z80644.1 IGHV3-64*04 37
EF542581.1 IGHV3-43*02 10
EF542586.1 IGHV3-60*01 19
Alignments are shown in Figures 2–4.
aIGHV3-23*01 sequences from healthy individuals obtained by single-cell PCR of
CD19+IgM+, CD19+IgM+CD5+, and CD19+IgD+CD27+ B cells (Brezinschek
et al., 1995, 1997; Dörner et al., 1998; Longo et al., 2008).
in unpaired or in ssDNA state (C’s or G’s, shown with arrows).
This structural analysis allows the speculation that the observed
GCV-like tracts in IGHV3-23∗01 sequences are initiated by the
DSB’s in the sequence-speciﬁc motifs owing to their localization
in the ssDNA state in stable SLSs.
COMPARISON OF GCV-LIKE EVENTS BETWEEN HEALTHY INDIVIDUALS,
CVID PATIENTS, AND AID-DEFICIENT PATIENTS
Our previous studies (Duvvuri et al., 2011, 2012) revealed SHM
patterns suggestive of defects in DNA repair mechanisms in
some CVID patients. Given the role of DNA repair processes
in GCV mechanisms, we compared the occurrence of GCV-like
events between two cohorts, CVID pts and healthy individuals.
Rearranged IGHV3-23∗01 gene sequences from CVID patients
showed signiﬁcantly lower levels of GCV-like events compared to
those of healthy individuals [1 event/161 sequences (0.621%) vs.
T a b l e4|C h a r a c t e r istics of base substitutions in GCV-like tracts shown
in Figure 1.
Recipient
sequencea
VH
region
Type of substitution GCV-like tract
length range
(in nucleotides) Silent Replacement
C2–C8 CDR1 AGC→AGT AGC→GAC
(S→D)
3–8
P1–5 CDR1 AGC→AGT AGC →GAT
(S→D)
13–47
aSequences starting with C and P are from healthy individuals and CVID patients
respectively.
8 events/121 sequences (6.61%) respectively; Fisher’s two-tailed
P-value=0.0057].
No GCV-like events were observed from any rearranged
IGHV3-23∗01 sequences of AID-deﬁcient patients.
In the analysis, although germline donors could be identiﬁed
forsinglebasechanges,evidenceof GCV-likeeventsrequiredclus-
tered templated mutations. Hence, only clustered mutations were
considered as evidence of GCV-like events. This criterion very
likely will underestimate the actual number of GCV-like events.
DISCUSSION
Our computational analysis of rearranged human IGHV3-23∗01
sequences led to the identiﬁcation of GCV-like events. GCV as
a means of generating antibody diversity is extensive in some
species especially in chicken (Reynaud et al., 1987, 1989, 1994;
McCormack et al., 1991; Sayegh et al., 1999; Arakawa and Buer-
stedde, 2004; Ratcliffe, 2006). Deﬁnitive evidence of GCV-like
events in human rearranged immunoglobulin genes has been
scarce (Darlow and Stott,2006).
EXCLUDING POTENTIAL PCR ARTIFACTS
VDJ chimeric molecules resembling somatic GCV can be pro-
duced during PCR in vitro b yap r o c e s sr e f e r r e dt oa s“ t e m -
plate jumping” (Pääbo et al., 1990; Brakenhoff et al., 1991). In
order to identify whether PCR artifacts were the likely cause for
the GCV-like events, we analyzed rearranged mutated IGHV3-
23∗01 sequences obtained from single-cell PCR from individual
B cell lysates from healthy individuals and AID-deﬁcient patients
(shown in Figures 2–4). AID is absolutely required for GCV in
immunoglobulin genes (Arakawa et al., 2002). The presence of
any GCV-like event in rearranged IGHV3-23∗01 sequences in
AID-deﬁcient patients would provide evidence of PCR artifacts.
In Figure 2, the rearranged sequences from single-cell PCR,
X87049.1, and X87051, had evidence of templated mutations
from germline VH3 donors downstream of the IGHV3-23∗01
gene. During V(D)J recombination at the human IGVH locus
downstream VH gene segments are deleted. Since these GCV-
like events are from single-cell PCR, the possible source of VH
donors for these GCV-like events could be from either the sister
chromatid or the homolog, that is, trans germline VH donors.
Our analysis on rearranged IGHV3-23∗01 sequences from AID-
deﬁcientpatientsdidnotrevealanyGCV-likeevents,includingno
sequencesthatcouldhavebeenchimericPCRartifacts.Thisresult
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Table 5 | Characteristics of base substitutions in GCV-like tracts superimposed by SHM shown in Figures 2–4.
Recipient sequencea VH region Type of substitution GCV-like tract length
range (in nucleotides)
Silent Replacement
X807049.1 CDR1 TTT→TTC AGC→AAC( S→N) 62
FR2 GCT→TCT (A→S)
X807050.1 CDR2 AGC→GAC( S→D) 14
AGC→GAC( S→D)
X807051.1 CDR1 AGC→AAC( S→N) 50
TAT →TGT (Y→C)
FR2 GGG→GGA AGC→GAC( S→D)
Z80511.1 CDR1 AGC→AGT AGC →AGT GCC→GAC( A→D) 11
Z80523.1 CDR1 TTT→TAC GCC→GTT 47
FR2 GGG→GGA AGC→AAC( S→N)
Z80644.1 FR2 AGC-AATT G G →TAT (W→Y) 37
EF542581.1 FR2 GCT→CTT( A→L) 10
EF542586.1 CDR2 GGT→ACC( G→T) 19
GGT→GAT( G→D)
FR3 TAC →CAC (Y →H)
aIGHV3-23*01 sequences from healthy individuals obtained by single-cell PCR of CD19+IgM+, CD19+IgM+CD5+, and CD19+IgD+CD27+ B cells (Brezinschek
et al., 1995, 1997; Dörner et al., 1998; Longo et al., 2008).
stronglyimplicatesthesourceof ouridentiﬁedGCV-likeeventsas
being from an in vivo mechanism that requires AID.
For the GCV-like events identiﬁed in IGHV3-23∗01 mutated
sequences in Figure 1, were obtained from total PBMC RNA, we
explored whether these events could be due to artifactual PCR
“jumping events.” Mutated IGHV3-23∗01 sequences shown in
Figure 1, are from two independent studies. C2–8 is from healthy
individual (Pan-Hammarström et al., 2006)a n dP - 5i sf r o ma
CVID patient (Levy et al., 1998). C2–8 and P1–5 sequences have
GCV-liketransferinthesameregion.Itisunlikelythattwosimilar
PCR-chimerascouldbeisolatedfromindependentPCRreactions.
In addition, sequences C2–8 and P1–5 resemble IGHV3-23∗01
downstream of the GCV-like event (underlined region), and not
the donor IGVH sequence. Thus for these sequences to be pro-
ducedbyaPCR-artifact,two“jumpevents”duringPCR,wouldbe
required: One“jump event”from the IGHV3-23∗01 template to a
donorsequencesandthesecondfromadonorsequencetoIGHV3-
23∗01.Andidentical“jumpevents”wouldhavehadtooccurintwo
different labs. We consider these scenarios to be unlikely and thus
we reason that the observed GCV-like transfer is most likely the
result of an in vivo GCV-like mechanism.
ThemechanismforthetemplatedmutationsshowninFigure6
remains questionable. These mutated IGHV3-23∗01 sequences
were obtained from total PBMC RNA (Levy et al., 1998; Pan-
Hammarström et al., 2006). Sinkora et al. (2000) demonstrated
that PCR generated VDJ chimeras occur predominantly in FR3
regions followed by FR2 (2000). Hence we considered whether
the GCV-like events, detailed in Figure 6, could be the result
of PCR-chimerism (“jump events”). Given that the examples
shown in Figure 6 have templated and un-templated mutations,
a characteristic expected of extensive in vivo antibody diversiﬁca-
tion, the possibility of them being true GCV-like events remains.
CRITICAL OBSERVATIONS OF GCV-LIKE EVENTS IN HUMAN
REARRANGED IGHV3-23∗01 GENE SEQUENCES
As the name implies, HR takes place between sequences that
have considerable similarity which is critical to stabilize DNA
pairing. All the identiﬁed germline GCV-like VH donors in this
study belong to the VH3 family, a highly homologous multigene
family. We found high similarity (>87%) between the poten-
tial germline VH donors and the IGHV3-23∗01 gene sequence.
These ﬁndings are consistent with the observations that GCV is
favored between highly similar genes usually with identity >80%
(Shen and Huang, 1986; David et al., 1992; Xu et al., 2008).
The length of identical region also signiﬁcantly affects the prob-
ability of GCV. It has been shown that GCV can occur with
regions of identity as small as ∼10bp (David et al., 1992). We
haveidentiﬁedminimum(3nts)andmaximum(62nts)sequence
identities between donor and recipient sequences that can serve
as targets for GCV and our ﬁndings are consistent with those
reportedinliterature(Davidetal.,1992).Allof theidentiﬁedtem-
plated mutations are clustered nucleotide differences. Clustering
is strong evidence for GCV. It is very unlikely that clustered tem-
plated diversity observed in the rearranged IGHV3-23∗01 gene
sequence is the result of independent somatic hypermutational
events.
The germline donor VH genes identiﬁed were upstream and
downstreamof therearrangedIGHV3-23∗01gene.Thesourcesof
donor DNA could be from sequences upstream of the rearranged
gene or from homologous DNA on the homolog or another chro-
mosome or from episomal remnants of VH to DHJH rearrange-
ments. Results of several studies over the years have suggested
that CSR can occur between the chromosomes, although the pre-
dominant mode of recombination is intrachromosomal. Trans-
chromosomal recombination between IGVH and Cα allotypes
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FIGURE 5 | Stem-loop structures of hypermutable bases in SHM/AID
hotspot motifs ﬂanking 5
  and 3
 of GCV-like tracts. DNA secondary
structures formed by folding germline IGHV3-23 sequence in program “mfg”
during simulated transcription (Wright et al., 2003, 2004, 2008a,b). Each
structure ﬂanking GCV-like tracts are named as the rearranged IGHV3-23*01
sequences shown in Figures 1–4.The hypermutable bases are shown with
arrows. DNA secondary structural parameters, −ΔG, % Unpaired (%UP)
correspond to hypermutable base (shown with arrows).
through GCV has been documented in rabbits (Tosi et al.,
1970; Pernis et al., 1973). Kingzette et al. (1998) documented
trans-chromosomal recombination at a high frequency (7%)
within the IGVH locus of rabbit B lymphocytes. Recombina-
tion between transgenicVHDJH gene and the endogenous IGVH
locus has also been shown to occur by interchromosomal GCV
in mice (Giusti and Manser, 1994). These studies demonstrated
that GCV can occur in trans. Given this evidence, it seemed
reasonable to us to expect GCV-like events could occur in trans in
humans.
SEQUENCE AND STRUCTURAL CONSIDERATION OF GCV-LIKE EVENTS
By modeling the dynamics of IGHV3-23∗01 DNA folding dur-
ing simulated transcription, we demonstrated the presence of
hypermutable bases, ﬂanking GCV-like tracts, in ssDNA of
stable SLSs.
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FIGURE 6 | Gene conversion-like events between rearranged
IGHV3-23*01 gene sequences and germlineVHsequences superimposed
by somatic hypermutation (SHM).Topmost sequence is the germline of
rearranged IGHV3-23*01 gene sequences from healthy individuals (C4–28,
C5–3, C5–6) and a CVID patient (P7–8). Potential donor germline IGHV3 family
gene segments are shown below the rearranged IGHV3-23*01 sequences.
GCV-like tracts are underlined. Flanking SHM/AID hotspot motifs are
underlined and italicized.
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There are two models to explain the generation of DSB’s in
DNA that initiate HR which can lead to GCV. In the ﬁrst model,
the excision of an AID-induced G:U lesion can result in an abasic
site,whichisthencleavedbyapurinic/apyrimidinicendonucleases
to generate DSB’s that can initiate HR (Casali and Zan, 2004). In
the second model,AID is dispensable for the generation of blunt-
ended DSB’s that preferentially occur in RGYW/WRCY motifs
(Unniraman et al., 2004). However, AID is critical for the gen-
eration of resected DSB’s that initiate strand invasion and the
subsequent repair of resected ends by HR in error-prone fash-
ion (Papavasiliou and Schatz,2002). Similarly to blunt end DSB’s,
resected ends also target RGYW/WRCY motifs (Papavasiliou and
Schatz, 2002; Zan et al., 2003). Whichever is the mechanism for
the generation of DSB’s that initiate HR, hypermutable bases of
the SHM hotspot motifs in ssDNA of stable SLSs can provide the
substrates for the initial or resected cleavage.
A model could be proposed for the role of transcription-
inducedDNAconformationininitiatingHR:studieshaveshowna
correlation between transcription strength and the degree of neg-
ative supercoiling. High rates of transcription as in VH genes can
induce supercoiling which in turn can promote the formation of
large DNA secondary structures (Liu and Wang,1987; Staudt and
Lenardo, 1991; Wright, 2000; Schmidt et al., 2006). Supercoiled
DNA and/or the large DNA secondary structures can promote
HR by bringing homologous DNA sequences closer together for
strand exchange. The hypermutable bases in ssDNA state in SLSs
can be targeted for DSB’s to initiate HR.
COMMON MUTATIONS ARE PRODUCTS OF GCV-LIKE EVENTS
One replacement mutation (Ser→Asp) at codon 31 that was
contained in clustered mutations is prominent in both healthy
individuals and CVID patients. This codon (AGC) at position 31
in CDR1 region was found to be highly mutable in other inde-
pendent mutational studies with IGHV3-23∗01 gene. Repeated
codon 31 mutations are apparently selected mutations following
afﬁnitymaturation.Thequestionis,isthisselectedmutationfrom
GCVorfromindependentSHMevents.Therehavebeeninstances
where independently generated antibodies shared four consecu-
tive identical amino acids in CDR2 and interestingly recognized
the same antigen. In that study,the authors could not identify any
obvious germline donors for the observed clustered mutations.
The absence of identiﬁed donors led to the conclusion that the
shared identical mutations were not products of GCV but likely
wereacquiredinindependentSHMeventsunderintenseselection
pressure for such mutated regions (Berek et al., 1987; Allen et al.,
1988; Claﬂin et al., 1989; Clarke et al., 1990; Wysocki et al., 1990).
A high incidence of shared mutations in independent products of
SHM has been observed in humans (van der Stoep et al., 1993).
Although independent SHM events cannot be ruled out,GCV-
like events could be responsible for these shared mutations at
codon31ofIGHV3-23∗01geneforthefollowingreasons:thereoc-
currence of identical mutations in mutated versions of the same
germline gene (IGHV3-23∗01), the identiﬁcation of germline
donors,and the length of matches (3–47nts). These reasons,con-
sistent with those reported in literature for GCV provide evidence
that the observed mutations are templated and the products of
single recombinational events.
GCV-LIKE EVENTS IN HEALTHY INDIVIDUALS, CVID, AND
AID-DEFICIENT PATIENTS
We have observed that the frequency of GCV-like events is signiﬁ-
cantlyhigherinrearrangedIGHV3-23∗01sequencesfromhealthy
individuals compared to that of CVID patients. CVID is a het-
erogeneous disorder of chieﬂy unknown cause (Sneller, 2001).
As the mechanism of GCV in human rearranged immunoglobu-
lin gene sequences is unknown, we are unable to conclude that
CVID patients have an enzymatic/mechanistic defect in GCV.
However, in the view of our previous study that some CVID
patients have defective MMR resolution of AID-induced muta-
tions, it remains that DNA repair defects in CVID patients could
that be responsible for the lower frequency of GCV-like events.
Additional support to our proposition comes from genetic associ-
ation studies in CVID patients that identiﬁed Mre11-Rad50-Nbs1
(MRN)complexdefectsintheirscreeningof 27DNArepairgenes
(Offer et al., 2010). MRN complex plays a crucial role in DSB
damage response in eukaryotic damage response via both the
HR and NHEJ pathways (Lamarche et al., 2010). CVID patients
demonstrate increased propensity to cancer and increased sen-
sitivity to ionizing radiation, both plausible outcomes of defec-
tive/inappropriate DNA repair mechanisms (Hermaszewski and
Webster, 1993; Vorechovský et al., 1993; Filipovich et al., 1994;
Palanduz et al.,1998; Gompels et al.,2003).
Our sequence analysis of IGHV3-23∗01 mutated sequences
from AID-deﬁcient patients (Longo et al., 2008) did not reveal
any evidence of GCV-like events. Our ﬁndings corroborates the
ﬁndings of other studies which have demonstrated that AID is
absolutely required for GCV in immunoglobulin genes (Arakawa
et al.,2002).
SUPPOSITION FOR RARITY OF GCV-LIKE EVENTS IN HUMAN
REARRANGED IMMUNOGLOBULIN GENES
Although GCV can generate rapid, extensive changes in
immunoglobulin genes in response to certain antigens, it is not
frequently observed in humans.
Gene conversion may not be required since considerable diver-
sity is present in primary immune repertoire and ﬁne tuning
through SHM is enough to generate potent immune response.
The identiﬁcation of templated mutations in human rearranged
IGHV3-23∗01 sequences steered us to search for alternate expla-
nations.
Thecomplexityofthemammalianimmunoglobulinlocimight
imposesomeunknownlimitationsforGCVinmammals.Itcould
also be due to the lack of homologous donor VH in accessible
chromatin (Xu and Selsing, 1994; Weill and Reynaud, 1996; Sale
etal.,2001).Therecouldbesomemechanisticdifferencesbetween
species that use GCV as a predominant mechanism of antibody
diversiﬁcation compared to the species that do not. For example,
humans have low frequency of HR activity compared to chickens
(Miyagawa et al., 2002). Low recombination frequency might be
thereasonforthelackofGCVinhumanrearrangedimmunoglob-
ulin genes, despite the presence of highly homologous germline
donors.Stillanotherexplanationisthepresenceof multiplenum-
bers of homologous sequences that might result in more than one
GCV event in a rearranged sequence and make it difﬁcult to the
identify donor sequences.
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The use of identical sequences from sister chromatid rather
than homologous (non-identical) sequences predominantly for
HR and the subsequent repair in error-prone manner can result
in mutations that will appear as un-templated mutations, even
though they are products of GCV-like events. Alternatively, high
ﬁdelity repair by HR using sister chromatid as template would
make GCV-like tracts invisible. Support comes from studies that
demonstratedthatinhypermutatingBcells,DSB’soccurpredomi-
nantlyinS/G2phasesof cellcycle(PapavasiliouandSchatz,2000).
HRispreferentiallyusedinS/G2phasesofcellcycleforDNAlesion
repair (Rothkamm et al.,2003). The cell cycle requirement for HR
likely reﬂects the necessity of sister chromatids as template for
DNArepairthroughHR.Insuchascenario,GCV-likemechanism
through HR would result in indiscernible GCV-like events, thus
leading to assumption that GCV-like events are absent or rare, as
in human rearranged immunoglobulin diversiﬁcation.
DIVERSIFICATION BY GCV-LIKE EVENTS
ThepurposeGCVafﬁnitymaturationinhumansremainsunclear.
The contribution to afﬁnity maturation by GCV can be quite
different from that of SHM. GCV, unlike SHM, can result in
multiple base substitutions that can alter many amino acids. In
chicken and rabbits a single round of GCV event has been shown
to affect 4–19 codons (Reynaud et al., 1987, 1989; Becker and
Knight, 1990). Thus the changes in afﬁnity generated by GCV
collectively are greater than the changes in afﬁnity made by indi-
vidual base substitutions. Such extensive changes in afﬁnity as a
result of GCV could be critical for clearance of highly mutat-
ing pathogens. Germline VH donors are evolutionarily selected.
It is advantageous to the species to encode the critical diversity
neededatbirthinthegermlineconﬁguration(BenedictandKear-
ney, 1999). Through mechanisms, like GCV, evolutionarily ﬁxed
germline diversity can be transferred to rearranged immunoglob-
ulin genes. On similar lines of receptor editing, the GCV base
substitutions in CDRs can altogether change the speciﬁcity of
antigenic receptor rather than just altering the afﬁnity of receptor
toward the antigen (characteristic of SHM). Such type of receptor
editing based on multiple templated mutations can prevent self-
reactivity of antigen receptors without too much wastage of the
primary immune repertoire.
In this study we have identiﬁed GCV-like events in human
rearranged IGHV3-23∗01 gene sequences,that account for 6.61%
in the healthy individuals. Given the potential for extensive
changes in antibody afﬁnity and/or speciﬁcity, this frequency of
GCV-like events would be instrumental in protecting humans
against pathogens that diversify their genome by antigenic
shift.
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